Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Phase 1 trial of DARE-FRT1 intravaginal ring for fertility and pregnancy maintenance

Trial Profile

A Phase 1 trial of DARE-FRT1 intravaginal ring for fertility and pregnancy maintenance

Status: Planning
Phase of Trial: Phase I

Latest Information Update: 07 Apr 2025

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Progesterone (Primary)
  • Indications Preterm labour
  • Focus Therapeutic Use

Most Recent Events

  • 31 Mar 2025 According to a Dare Bioscience media release, the company is conducting activities necessary to enable phase 1 study.
  • 13 Dec 2023 According to a Dare Bioscience media release, the company is eligible to receive up to a total of approximately $2 million in grant funding for its DARE-PTB1 program based on the grant application it submitted to support a DARE-PTB1 Phase 1 human clinical study.
  • 30 Mar 2021 According to a Dare Bioscience media release, initiation of this trial is targeted for 2022.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top